
    
      Furoscix 80 mg will be administered as a subcutaneous infusion following a step-wise decrease
      in infusion times starting with a 5 hour infusion time. Subsequent cohorts will enroll
      following a safety assessment of the prior cohort. While maintaining the 80 mg dose, infusion
      time will ultimately be reduced to 30 minutes.
    
  